Skip to main content
CTVA
NYSE Industrial Applications And Services

Corteva 10-Q Details $527M Q3 Continuing-Ops Loss and $7.4B Debt After Vylor Spin-Off

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Healthcare
Sentiment info
Negative
Importance info
8
Price
$9.26
Mkt Cap
$6.132B
52W Low
$9.14
52W High
$14.62
52W Position info
1.3% above low
Off High info
37% below high
Rel. Volume info
2.0× avg
Market data snapshot near publication time

CTVA is trading near its 52-week low of $9.14 (1.3% above the low) on elevated volume (2.0× avg).

Summary

Corteva's Q3 10-Q shows a $(527) million loss from continuing operations and operating EBITDA of $(68) million, with total debt up to $7,446 million after the October 1 Vylor spin-off and nine-month operating cash flow of $(3,878) million.


Key Events · Earnings and Guidance · CTVA

  • Q3 Loss and EBITDA Swing Negative

    Net sales fell 6% to $2,458 million from $2,618 million, and operating EBITDA swung to $(68) million from $49 million a year earlier on Crop Protection pricing pressure and lower volumes.

  • Debt Jumps to $7.4 Billion

    Total debt rose to $7,446 million from $2,580 million at December 31, 2025, with short-term borrowings at $3,988 million versus $894 million, reflecting spin-off capital structure work and working capital funding.

  • Nine-Month Cash Burn of $3.9 Billion

    Operating cash flow from continuing operations was $(3,878) million versus $(941) million a year earlier, driven by the $1.5 billion discretionary pension contribution and the $610 million Bayer settlement payment.

  • Vylor Spin-Off Closed October 1

    Corteva received a $761 million cash distribution from Vylor and used it to repay the $600 million 364-day facility balance and $161 million of commercial paper; the remaining company is the Crop Protection business.


Analysis · CTVA · Industrial Applications And Services

The headline Q3 loss was already public, but the 10-Q reveals how much the balance sheet has changed: total debt jumped to $7,446 million from $2,580 million at year-end 2025, with short-term borrowings at $3,988 million versus $894 million. Nine-month operating cash flow was an outflow of $(3,878) million, driven by a $1.5 billion discretionary pension contribution and the $610 million Bayer settlement payment. The Vylor spin-off closed October 1, 2026, and Corteva received a $761 million cash distribution that it used to repay the $600 million 364-day facility and $161 million of commercial paper. With the stock near its 52-week low, the market is now pricing a smaller, more leveraged Crop Protection-only company whose Q3 operating EBITDA was $(68) million.

How filings like this one have moved

In the 30 days to Nov 12, 2026, 47.3% of the 1873 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.17%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, CTVA was trading at $9.26 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $6.1B. The 52-week trading range was $9.14 to $14.62. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

CTVA - Latest Insights

CTVA
Nov 12, 2026, 11:47 AM EST
Source: Reuters
Importance Score:
8
Price at Filing: $9.82
Real-time Price: $9.25 info
Change: -$0.5635 (-6%) info
Market Cap: $6.132B info
CTVA
Nov 12, 2026, 8:34 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $10.89
Real-time Price: $9.25 info
Change: -$1.64 (-15%) info
Market Cap: $6.132B info
CTVA
Nov 12, 2026, 5:45 AM EST
Source: Benzinga
Importance Score:
8
Price at Filing: $10.89
Real-time Price: $9.25 info
Change: -$1.64 (-15%) info
Market Cap: $6.132B info
CTVA
Nov 11, 2026, 4:30 PM EST
Source: PR Newswire
Importance Score:
8
Price at Filing: $12.19
Real-time Price: $9.25 info
Change: -$2.94 (-24%) info
Market Cap: $6.132B info
CTVA
Nov 10, 2026, 5:49 PM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $12.13
Real-time Price: $9.25 info
Change: -$2.88 (-24%) info
Market Cap: $6.132B info